SI-BONE To Present at Canaccord Genuity 44th Annual Growth Conference on August 14, 2024
SI-BONE (Nasdaq: SIBN), a medical device company focused on sacropelvic disorders, has announced its participation in the Canaccord Genuity 44th Annual Growth Conference in Boston. The company's management will host a fireside chat on August 14, 2024, at 3:30 p.m. Eastern Time.
Investors can listen to the conference call by registering through a provided link. The webcast will be available live on the 'Investors' section of SI-BONE's website and will be archived for at least 90 days after the event. This presentation offers an opportunity for investors to gain insights into SI-BONE's growth strategies and market position in the medical device industry.
SI-BONE (Nasdaq: SIBN), un'azienda medica specializzata nei disturbi sacropelvici, ha annunciato la sua partecipazione alla 44esima Conferenza Annuale sulla Crescita di Canaccord Genuity a Boston. La direzione dell'azienda condurrà una chiacchierata informale il 14 agosto 2024, alle 15:30 ora orientale.
Gli investitori possono ascoltare la chiamata della conferenza registrandosi tramite un link fornito. La trasmissione sarà disponibile in diretta nella sezione 'Investitori' del sito web di SI-BONE e sarà archiviata per almeno 90 giorni dopo l'evento. Questa presentazione offre un'opportunità agli investitori per acquisire informazioni sulle strategie di crescita e sulla posizione di mercato di SI-BONE nell'industria dei dispositivi medici.
SI-BONE (Nasdaq: SIBN), una empresa de dispositivos médicos enfocada en trastornos sacropélvicos, ha anunciado su participación en la 44ª Conferencia Anual de Crecimiento de Canaccord Genuity en Boston. La dirección de la empresa llevará a cabo una charla informal el 14 de agosto de 2024, a las 3:30 p.m. hora del Este.
Los inversores pueden escuchar la llamada de la conferencia registrándose a través de un enlace proporcionado. La transmisión estará disponible en vivo en la sección 'Inversores' del sitio web de SI-BONE y se archivarará durante al menos 90 días después del evento. Esta presentación ofrece a los inversores una oportunidad para obtener información sobre las estrategias de crecimiento y la posición de mercado de SI-BONE en la industria de dispositivos médicos.
SI-BONE (Nasdaq: SIBN), 골반 및 척추 장애에 집중하는 의료 기기 회사가 보스턴에서 열리는 캐나다 고투 이 44번째 연례 성장 컨퍼런스에 참석한다고 발표했습니다. 회사 경영진은 2024년 8월 14일 오후 3시 30분 동부 표준시에 파이어사이드 채팅을 진행합니다.
투자자는 제공된 링크를 통해 등록하여 컨퍼런스 콜을 들을 수 있습니다. 웹캐스트는 SI-BONE 웹사이트의 '투자자' 섹션에서 실시간으로 제공되며 이벤트 이후 최소 90일 동안 아카이브됩니다. 이 프레젠테이션은 투자자에게 SI-BONE의 성장 전략 및 의료 기기 산업 내 시장 위치에 대한 통찰을 얻을 수 있는 기회를 제공합니다.
SI-BONE (Nasdaq: SIBN), une entreprise de dispositifs médicaux spécialisée dans les troubles sacro-pelviens, a annoncé sa participation à la 44e conférence annuelle sur la croissance de Canaccord Genuity à Boston. La direction de l'entreprise animera une discussion informelle le 14 août 2024 à 15h30, heure de l'Est.
Les investisseurs peuvent écouter l'appel de la conférence en s'inscrivant via un lien fourni. Le webinaire sera disponible en direct dans la section 'Investisseurs' du site de SI-BONE et sera archivé pendant au moins 90 jours après l'événement. Cette présentation offre aux investisseurs une opportunité d'obtenir des informations sur les stratégies de croissance et la position de marché de SI-BONE dans l'industrie des dispositifs médicaux.
SI-BONE (Nasdaq: SIBN), ein Medizintechnikunternehmen, das auf sakropelvine Störungen spezialisiert ist, hat seine Teilnahme an der 44. jährlichen Wachstums-Konferenz von Canaccord Genuity in Boston bekannt gegeben. Das Management des Unternehmens wird am 14. August 2024 um 15:30 Uhr (Eastern Time) eine informelle Diskussion führen.
Investoren können an dem Konferenzanruf teilnehmen, indem sie sich über einen bereitgestellten Link registrieren. Das Webcast wird live im Bereich 'Investoren' auf der Website von SI-BONE verfügbar sein und mindestens 90 Tage nach der Veranstaltung archiviert werden. Diese Präsentation bietet Investoren die Möglichkeit, Einblicke in die Wachstumsstrategien und die Marktposition von SI-BONE in der Medizintechnikbranche zu gewinnen.
- None.
- None.
SANTA CLARA, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will be participating in the upcoming 2024 Canaccord Genuity 44th Annual Growth Conference in Boston. Management will be hosting a fireside chat on Wednesday, August 14th, 2024, at 3:30 p.m. Eastern Time/ 1:30 p.m. Pacific Time.
Investors interested in listening to the conference call may do so by registering at this link: https://url.us.m.mimecastprotect.com/s/1f7GCNk84yt0E1qNsm3zxj?domain=wsw.com. Live audio of the webcast will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event.
About SI-BONE, Inc.
SI-BONE (NASDAQ: SIBN) is a global leader in developing unique technologies for surgical treatment of sacropelvic disorders. Since pioneering minimally invasive SI joint surgery in 2009, SI-BONE has supported over 3,900 physicians in performing a total of over 100,000 procedures. A unique body of clinical evidence supports the use of SI-BONE’s technologies, including two randomized controlled trials and over 130 peer reviewed publications. SI-BONE has leveraged its leadership in minimally invasive SI joint fusion to commercialize novel solutions for adjacent markets, including adult deformity, spinopelvic fixation and pelvic trauma.
For additional information on the company or the products including risks and benefits, please visit www.si-bone.com.
iFuse Bedrock Granite, iFuse-TORQ, SI-BONE and iFuse INTRA are registered trademarks of SI-BONE, Inc. ©2024 SI-BONE, Inc. All Rights Reserved.
Investor Contact: Saqib Iqbal investors@si-bone.com
FAQ
When is SI-BONE (SIBN) presenting at the Canaccord Genuity Growth Conference in 2024?
How can investors listen to SI-BONE's (SIBN) presentation at the Canaccord Genuity conference?
How long will the webcast of SI-BONE's (SIBN) presentation be available for replay?
What is the focus of SI-BONE (SIBN) as a medical device company?
